ArticleMaterials today. Bio2026
Mechanoregulative hydrogel enables scar-reduced and functional healing of infected diabetic mobile wounds.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic infected wounds at mobile sites are characterized by persistent hyperglycemia, oxidative stress, and drug-resistant bacterial colonization, which collectively establish a self-amplifying infection-inflammation cycle. Meanwhile, wounds located at mechanically active regions, such as the nape and joints, are continuously exposed to stretching and repetitive deformation, leading to heterogeneous stress distribution at the wound edge, fibrotic remodeling, and hypertrophic scar formation. Therefore, simultaneous regulation of biochemical pathology and mechanical imbalance is essential for high-quality healing of diabetic mobile wounds. Here, we develop a multilevel mechanoregulative hydrogel to coordinately regulate the bio-mechanical microenvironment of diabetic infected wounds at mobile sites. The inner dynamic boronate ester network functions as a glucose-responsive delivery platform for on-demand release of polyhexamethylene biguanide (PHMB) and oxidative stress-balancing OPC-Ce nanoparticles (OPC-Ce NPs), enabling efficient eradication of drug-resistant bacteria, ROS scavenging, and inflammatory microenvironment remodeling. The outer elastic network absorbs, disperses, and homogenizes wound-edge forces to reconfigure local stress distribution, thereby suppressing fibrosis activation in high-stress regions while improving impaired cellular activity in low-stress regions. In addition, the outer layer recaptures excess PHMB, reducing cytotoxicity associated with prolonged antibacterial exposure. In vivo, this hydrogel markedly promotes ordered regeneration of diabetic mobile wounds, as evidenced by normalized epidermal differentiation, enhanced hair follicle neogenesis, restrained dermal fibroblast overactivation, and functional remodeling of neovasculature and extracellular matrix. This study establishes a therapeutic strategy that integrates anti-infective/anti-inflammatory regulation, dynamic antibacterial agent management, and mechanical stress regulation, offering a new materials paradigm for scar-reduced repair of infected diabetic wounds on mobile joints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.